Rationale Efficacy and Safety Evidence of Lenvatinib and Pembrolizumab Association in Anaplastic Thyroid Carcinoma

Anaplastic thyroid carcinoma (ATC) are highly aggressive malignant tumors with poor overall prognosis despite multimodal therapy. As ATC are extremely rare, no randomized controlled study has been published for metastatic disease. Thyrosine kinase inhibitors, especially lenvatinib and immune checkpo...

Descripción completa

Detalles Bibliográficos
Autores principales: Boudin, Laurys, Morvan, Jean-Baptiste, Thariat, Juliette, Métivier, Denis, Marcy, Pierre-Yves, Delarbre, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601195/
https://www.ncbi.nlm.nih.gov/pubmed/36290887
http://dx.doi.org/10.3390/curroncol29100610

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9601195/
https://www.ncbi.nlm.nih.gov/pubmed/36290887
http://dx.doi.org/10.3390/curroncol29100610

Ejemplares similares